4,079
Views
124
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause

, &
Pages 757-763 | Received 20 Feb 2015, Accepted 21 Apr 2015, Published online: 15 Jul 2015

References

  • Portman DJ, Gass MLS, on behalf of the Vulvovaginal Atrophy Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
  • Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
  • Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
  • Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int 2013;19:155–62
  • Robinson D, Cardozo L. The pathophysiology and management of postmenopausal urogenital oestrogen deficiency. J Br Menopause Soc 2001;7:67–73
  • Ettinger B, Hait H, Reape KZ, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;15:885–9
  • Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5: 437–47
  • Oge T, Hassa H, Aydin Y, Yalcin OT, Colak E. The relationship between urogenital symptoms and climacteric complaints. Climacteric 2013;16:646–52
  • Suckling JA, Kennedy R, Lethaby A, Roberts H. Local estrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;(4):1–104
  • Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133–42
  • MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87–94
  • Santen RJ, Allred DC, Ardoin SP, et al. Executive summary: Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(Suppl 1):s1–66
  • The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19:257–71
  • de Villiers TJ, Gass MLS, Haines CJ, et al. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric 2013;16:203–4
  • de Villiers TJ, Pines A, Panay N, et al., on behalf of the International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
  • Giarenis I, Cardozo L. Managing urinary incontinence: what works? Climacteric 2014;17(Suppl 2):26–33
  • Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2012;10:CD001405
  • Nelken RS, Ozel BZ, Leegant AR, Felix JC, Mishell DR. Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause 2011;18:962–6
  • Tseng LH, Wang AC, Chang YL, Soong YK, Lloyd LK, Ko YJ. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome. Neurourol Urodyn 2009;28:47–51
  • Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17:363–9
  • Kaufmann R, Hibst R. Pulsed Erbium: YAG laser ablation in cutaneous surgery. Lasers Surg Med 1996;19:324–30
  • Reynolds N, Cawrse N, Burge T, Kenealy J. Debridement of a mixed partial and full thickness burn with an erbium: YAG laser. Burns 2003;29:183–8
  • Baraldi CE, Puricelli E, Kulkes S, Martins GL. Er: YAG laser in oral soft tissue surgery. J Oral Laser Applications 2001;1:24
  • Levy JL, Trelles MA. New operative technique for treatment of xanthelasma palpebrarum: laser inverted resurfacing: preliminary report. Ann Plast Surg 2003;50:339–43
  • Vizintin Z, Rivera M, Fistonic I, et al. Novel minimally invasive VSP Er: YAG laser treatments in gynecology. J Laser Health Acad 2012;1:46–58
  • Gaspar A. Comparison of new minimally invasive Er: YAG laser treatment and hormonal replacement therapy in the treatment of vaginal atrophy. Climacteric 2014;17(Suppl 1):124
  • Cano A, Estevez J, Usandizaga R, et al. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Menopause 2012;19:1130–9
  • Bachmann GA, Notelovitz M, Kelly SJ, et al. Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sexuality 1992;8:3–8
  • Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2014;161:429–40
  • Fistonic I. Laser treatment of early stages of stress urinary incontinence significantly improves sexual life. Presented at Annual Conference of European Society for Sexual Medicine, December 2012, Amsterdam
  • Fistonic I. Erbium laser treatment for early stages of stress urinary incontinence (SUI) in women. Presented at Annual Meeting of International Urogynecological Association, May 2013, Dublin
  • Fistonic I. Erbium laser treatment for early stages of stress urinary incontinence (SUI) and vaginal relaxation significantly improves pelvic floor function. Presented at 15th Congress of Human Reproduction, March 2013, Venice